Shire Plc (SHP) pulled off a settlement agreement with Teva Pharmaceutical Industries Ltd. (TEVA), enabling the later to manufacture cheap generic copies of Intuniv.
Tags: Shire PLC
Canada's Valeant to acquire Salix in $10.1 billion deal
Canada's Valeant Pharmaceuticals International Inc.
Shire to buy NPS for $5.2 billion to boost rare disease drugs
Shire Plc has agreed to buy NPS Pharmaceuticals Inc for $5.2 billion in its biggest acquisition yet, as the Dublin-based drugmaker strengthens its position in the lucrative field of medicines for rare diseases.
Elliott Associates may sue AbbVie over scuttled deal
Hedge fund Elliott Associates may take legal action against pharmaceuticals company AbbVie Inc for scuttling a merger deal with Shire Plc.
AbbVie says to reconsider recommendation for Shire acquisition
AbbVie Inc (ABBV.N) said it intends to reconsider its recommendation to its shareholders to vote in favor of the 32 billion pound ($54.7 billion) merger with Shire Plc (SHP.L) due to the changing U.S. tax regulations.
Latest News
1
